Effect of bisphosphonate on bone microstructure, mechanical strength in osteoporotic rats by ovariectomy.

Autor: Wang, Yuzhu¹ (AUTHOR), Wu, Zhanglin² (AUTHOR), Li, Chun¹ (AUTHOR), Ma, Chenhao¹ (AUTHOR), Chen, Jingyang¹ (AUTHOR), Wang, Mincong² (AUTHOR) Mincong1215@sina.com, Gao, Dawei¹ (AUTHOR), Wu, Yufeng¹ (AUTHOR), Wang, Haibin³ (AUTHOR)

Publikováno v: BMC Musculoskeletal Disorders. 9/10/2024, Vol. 25 Issue 1, p1-12. 12p.

经胰岛素泵强化治疗后转换为德谷胰岛素利拉鲁肽 注射液治疗的2型糖尿病患者2例

Autor: 万晓铮^1,2, 张志梅², 甘可欣², 吕秀芹², 章冬梅², 刘晶^1,2 liujing981531@163.com

Publikováno v: Chinese Journal of Diabetes Mellitus. 2024 Special Issue, Vol. 16, p102-105. 4p.

Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin's lymphoma and responding to doxorubicin treatment: case report and review of the literature.

Autor: Lekovic GP; House Clinic, House Ear Institute, 2100 West Third Street, Los Angeles, CA, 90057, USA. glekovic@houseclinic.com., Batra A; House Clinic, House Ear Institute, 2100 West Third Street, Los Angeles, CA, 90057, USA., Barnard ZR; House Clinic, House Ear Institute, 2100 West Third Street, Los Angeles, CA, 90057, USA., Wilkinson EP; House Clinic, House Ear Institute, 2100 West Third Street, Los Angeles, CA, 90057, USA., Balena R; John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA, 90404, USA., Palejwala S; John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA, 90404, USA., Barkhoudarian G; John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA, 90404, USA.

Publikováno v: Acta neurochirurgica [Acta Neurochir (Wien)] 2018 Dec; Vol. 160 (12), pp. 2363-2366. Date of Electronic Publication: 2018 Oct 29.

Prevention of early postmenopausal bone loss with cyclical etidronate

Autor: Adami, Silvano, Bruni, V., Bianchini, D., Becorpi, A., Lombardi, P., Campagnoli, C., Ferrari, A., Marchesini, T. BALENA R.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1943::ab05f9d1f3abb48750ddeb9e2be381fb
http://hdl.handle.net/11562/307179

Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial.

Autor: Nauck, M., Horton, E., Andjelkovic, M., Ampudia‐Blasco, F. J., Parusel, C. T., Boldrin, M., Balena, R.

Publikováno v: Diabetic Medicine; Jan2013, Vol. 30 Issue 1, p109-113, 5p, 1 Chart, 1 Graph